Integration of Insulin receptor/Foxo signaling and dMyc activity during muscle growth regulates body size in Drosophila
MetadataShow full item record
CitationDemontis, F., and N. Perrimon. 2009. “Integration of Insulin Receptor/Foxo Signaling and dMyc Activity during Muscle Growth Regulates Body Size in Drosophila.” Development 136 (6): 983–93. https://doi.org/10.1242/dev.027466.
AbstractDrosophila larval skeletal muscles are single, multinucleated cells of different sizes that undergo tremendous growth within a few days. The mechanisms underlying this growth in concert with overall body growth are unknown. We find that the size of individual muscles correlates with the number of nuclei per muscle cell and with increasing nuclear ploidy during development. Inhibition of Insulin receptor (InR; Insulin-like receptor) signaling in muscles autonomously reduces muscle size and systemically affects the size of other tissues, organs and indeed the entire body, most likely by regulating feeding behavior. In muscles, InR/Tor signaling, Foxo and dMyc (Diminutive) are key regulators of endoreplication, which is necessary but not sufficient to induce growth. Mechanistically, InR/Foxo signaling controls cell cycle progression by modulating dmyc expression and dMyc transcriptional activity. Thus, maximal dMyc transcriptional activity depends on InR to control muscle mass, which in turn induces a systemic behavioral response to allocate body size and proportions.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:41384463
- HMS Scholarly Articles